王玉明，汉族，中共党员，博士，副教授，硕士生导师。博士毕业于天津中医药大学，清华大学访问学者，现任天津中医药大学中药学院药物分析教研室主任。
主要从事中药分析及代谢组学研究。主持国家自然科学基金1项、天津市医药科技重大专项（子任务）1项、横向课题3项。第一或通讯作者在ACS Nano、Acta Pharmaceutica Sinica B、Chinese Chemical Letters、Food Research International、Journal of Ethnopharmacology等学术期刊发表论文40余篇，单篇最高影响因子16.0。担任教育部高等学校中药分析学课程联盟理事，参编《中药分析学》、《药物分析》等“十四五”、“十五五”规划教材4部。主持天津市教改课题1项、校级教改课题1项；作为主要发明人申请专利5项，获专利授权2项；作为主要完成人荣获天津市科技进步特等奖1项、天津市科技进步二等奖1项、中国民族医药学会一等奖1项、中华中医药学会二等奖1项。
承担科研项目情况：
1.国家自然科学基金青年项目，基于功能代谢组学探讨薏苡附子散治疗类风湿性关节炎和慢性心力衰竭“异病同治”的生物学机制，2020/01-2022/12，21万元，结题，主持。
2.天津市科学技术局重大专项项目（任务负责人），面向临床代谢组学的高灵敏质谱痕量检测系统研发及工程化，2025/10-2028/09，30万元，在研，主持。
3. 企业横向课题, 基于活性代谢组学风湿骨痛胶囊治疗骨骼肌肉疼痛的生物学机制研究, 2024/06-2026/05, 68.18万元, 在研, 主持。
4. 国家自然科学基金委联合基金项目, 基于免疫衰老解析加减葳蕤汤防治呼吸道病毒感染的药效物质及生物学基础研究, 2026/01-2029/12, 257万元, 在研, 参与。
主要代表性成果：
[1] Yuming Wang#, Ni Fan#, Rui Wang#, Xue Li, Feng Zhao, Lin Miao, Xi Wang, Xiaohui Yan, Zhang Zhang, Xuanjun Wu, Zhonggao Gao*, Yunfei Li*, Yubo Li*. Discovery of Airway-Administered Ionophores for Mn2+ to Mitigate Lung Metastasis by Targeting Disseminated Tumor Cell. ACS Nano., 2025,19(14):14330-14350. [IF=16.0]
[2] Ruixuan Zhang#, Yunfei Li#, Hui Fu#, Chengcheng Zhao, Xiuyan Li, Yuming Wang*, Yujiao Sun*, Yingpeng Li*, Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy. Acta Pharmaceutica Sinica B. 2025,15(9):4582-4613. [IF=14.6]
[3] Chengying Wang#, Bohan Chen#, Yuming Wang#, Bingyu Xie, Peishuang Yu, Xiaojie Xu, Rui Wang, Lin Miao, Xiaohui Yan, Yubo Li*, Yunfei Li*, Wei Huang*. Advances of nanomedicine targeting the interface of cholesterol metabolism and immune evasion. Chin Chem Lett., 2025, 110921. [IF=8.9]
[4] Liping Huang#, Fangfang Zhang#, Yuyu Wang, Junke Wu, Rui Wang, Shuang Wei, Xinyu Li, Nanjian Xu*, Yuming Wang*, Yubo Li*. J Ethnopharmacol.,2025, 348:119842.[IF=5.4]
[5] Yuming Wang#, Junke Wu#, Tingting Lian, Yuyu Wang, Fangfang Zhang, Xue Li, Yanyan Xu*, Shiqiao Liu*, Yubo Li*. Exploring chemical markers and identifying phenolic markers using a metabolomics strategy and chemometrics to study the different origins of defatted Coix seed. Food Res Int., 2024,194:114864. [IF=8.0]
[6] Xicheng He#, Yuming Wang#, Haixiang Li, Min Han, Zhixuan Feng, Kunze Du*, Xiaoxia Li*. Approach for concurrent detection and removal of diclofenac in wastewater: Integration of MOF with Poly(deep eutectic solvent) imprinting method, Journal of Environmental Chemical Engineering, 2024, 12:114107. [IF=7.2]
[7] Yuming Wang#, Fangfang Zhang#, Xiaokai Li#, Xue Li, Jiayi Wang, Junjie He, Xiaoyan Wu, Siyu Chen, Yanjun Zhang*, Yubo Li*. Integrated Multi-omics techniques and Network Pharmacology Analysis to Explore the Material Basis and Mechanism of Simiao Pill in the Treatment of Rheumatoid Arthritis. ACS Omega, 2023, 8(12):11138-11150. [IF=4.3]
[8] Yuming Wang#, Xue Li#, Min Qi, Xiaokai Li, Fangfang Zhang, Yuyu Wang, Junke Wu, Lexin Shu, Simiao Fan, Yunfei Li*, Yubo Li*. Pharmacological effects and mechanisms of YiYiFuZi powder in chronic heart disease revealed by metabolomics and network pharmacology. Front Mol Biosci., 2023, 10:1203208. [IF=4.0]
[9] Yuming Wang#, Xiaokai Li#, Kun Gu#, Jing Gou, Xue Li, Yaqian Dong, Rui Li, Jinxia Wei*, Zhiying Dou*, Yubo Li*. Study on the potential mechanism of the active components in YiYiFuZi powder in homotherapy for hetropathy ofcoronary heart disease and rheumatoid arthritis. Front Chem., 2022, 10: 926950. [IF=4.2]
[10] Yu Yuan#, Simiao Fan#, Lexin Shu#, Wei Huang#, Lijuan Xie, Chenghao Bi, Hongxin Yu, Yuming Wang*, Yubo Li*. Exploration the Mechanism of Doxorubicin-Induced Heart Failure in Rats by Integration of Proteomics and Metabolomics Data. Front Pharmacol., 2020, 11: 600561. [IF=4.8]
联系方式：wangyuming226@163.com.
